Stănescu D C, Teculescu D B
Thorax. 1970 Sep;25(5):581-6. doi: 10.1136/thx.25.5.581.
In 11 patients with bronchial asthma, lung volumes, FEV, PaO, and lung diffusing capacity (single breath CO method) were measured in status asthmaticus and after recovery. Ventilatory capacity improved following therapy. The improvement was associated with a rise in vital capacity and a fall in residual volume, but the total lung capacity might either decrease, increase or remain unchanged. A decreased value of PaO was found in all patients in status asthmaticus. After treatment PaO increased in all patients. In two of them PaO increased despite the unchanged values of the other parameters of pulmonary function. The improvement of PaO after treatment is considered to be the result of adjustment of perfusion to ventilation. The lung diffusing capacity was below normal values in three patients before treatment. After treatment the diffusing capacity increased in six patients. The diffusion constant, although within the normal range in status asthmaticus, increased after treatment in one and decreased in three other patients. The decreased diffusing capacity in status asthmaticus is the consequence of a reduced effective alveolar volume due to uneven distribution of ventilation. The changes observed in the diffusion constant following corticotherapy are ascribed to a dependence of this constant on the different level of the alveolar volume at which the single breath test is performed.
对11例支气管哮喘患者在哮喘持续状态及恢复后测量了肺容量、第一秒用力呼气量(FEV)、动脉血氧分压(PaO)和肺弥散容量(单次呼吸一氧化碳法)。治疗后通气能力有所改善。这种改善与肺活量增加和残气量减少有关,但肺总量可能减少、增加或保持不变。所有哮喘持续状态患者的PaO值均降低。治疗后所有患者的PaO均升高。其中2例患者尽管肺功能的其他参数值未变,但PaO仍升高。治疗后PaO的改善被认为是灌注与通气调整的结果。3例患者治疗前肺弥散容量低于正常值。治疗后6例患者的弥散容量增加。弥散常数在哮喘持续状态时虽在正常范围内,但治疗后1例患者增加,另3例患者降低。哮喘持续状态时弥散容量降低是由于通气分布不均导致有效肺泡容积减少的结果。皮质激素治疗后弥散常数的变化归因于该常数依赖于进行单次呼吸试验时不同水平的肺泡容积。